尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Ramelmeier Rolf Andrew, Vice-Président Exécutif, Opérations Techniques. Director active across 1 company, notably Sangamo Therapeutics, INC. Aggregated, 3 filings have been logged. Activity tracked since 25 February 2022. The latest transaction was disclosed on 25 May 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Rolf Andrew Ramelmeier is the EVP of Technical Operations at SANGAMO THERAPEUTICS, INC. He is responsible for leading technical operations and implementing strategic initiatives. His role is essential for ensuring innovation and operational efficiency.